Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viral therapy of glioblastoma multiforme.

Literature DB >> 23836634

Viral therapy of glioblastoma multiforme.

Richard J Whitley¹, James M Markert.

Abstract

Entities: Disease

Mesh：

Substances：
Interleukin-12

Year: 2013 PMID： 23836634 PMCID： PMC3718094 DOI： 10.1073/pnas.1310253110

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

13 in total

1. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.

Authors: J N Parker; G Y Gillespie; C E Love; S Randall; R J Whitley; J M Markert
Journal: Proc Natl Acad Sci U S A Date: 2000-02-29 Impact factor: 11.205

2. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.

Authors: R J Whitley; E R Kern; S Chatterjee; J Chou; B Roizman
Journal: J Clin Invest Date: 1993-06 Impact factor: 14.808

3. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.

Authors: J Chou; E R Kern; R J Whitley; B Roizman
Journal: Science Date: 1990-11-30 Impact factor: 47.728

4. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.

Authors: Elizabeth K Hellums; James M Markert; Jacqueline N Parker; Bin He; Bernard Perbal; Bernard Roizman; Richard J Whitley; Catherine P Langford; Suman Bharara; G Yancey Gillespie
Journal: Neuro Oncol Date: 2005-07 Impact factor: 12.300

5. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.

Authors: Ta-Chiang Liu; Tingguo Zhang; Hiroshi Fukuhara; Toshihiko Kuroda; Tomoki Todo; Xavier Canron; Andreas Bikfalvi; Robert L Martuza; Andreas Kurtz; Samuel D Rabkin
Journal: Clin Cancer Res Date: 2006-11-15 Impact factor: 12.531

6. Morphological, electrophysiological, and synaptic properties of corticocallosal pyramidal cells in the neonatal rat neocortex.

Authors: Jean-Vincent Le Bé; Gilad Silberberg; Yun Wang; Henry Markram
Journal: Cereb Cortex Date: 2006-11-23 Impact factor: 5.357

Review 3. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.

Authors: Qing Zhang; Fusheng Liu
Journal: Cell Death Dis Date: 2020-06-25 Impact factor: 8.469

4. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.

Authors: Laura Menotti; Elisa Avitabile; Valentina Gatta; Paolo Malatesta; Biljana Petrovic; Gabriella Campadelli-Fiume
Journal: Viruses Date: 2018-06-30 Impact factor: 5.048

4 in total

Viral therapy of glioblastoma multiforme.

1. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.

2. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.

3. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.

4. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.

5. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.

6. Morphological, electrophysiological, and synaptic properties of corticocallosal pyramidal cells in the neonatal rat neocortex.

7. Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.

8. Cancerous stem cells can arise from pediatric brain tumors.

9. Identification of a cancer stem cell in human brain tumors.

10. Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.

1. Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.

2. Third Ventricular Glioblastoma Multiforme: Case Report and Literature Review.

Review 3. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.

4. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.